BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossifica… Post author:Sam Post published:January 4, 2018 Post category:BioPharma FOP is a very rare disease that affects approximately 1 in 2 million people worldwide. Source: BioSpace You Might Also Like Motif Bio Explodes After Phase III Clinical Trial Success October 3, 2017 Concert Pharma Reports Second Quarter 2017 Financial Results And Provides Company Update August 7, 2017 Seegene Enters The U.S. Diagnostic Market In Collaboration With Thermo Fisher Scientific May 22, 2017
Concert Pharma Reports Second Quarter 2017 Financial Results And Provides Company Update August 7, 2017
Seegene Enters The U.S. Diagnostic Market In Collaboration With Thermo Fisher Scientific May 22, 2017
